Revenue expectations have to be tempered. Here is
Post# of 30028
Posted On: 11/08/2014 6:56:12 PM
Revenue expectations have to be tempered. Here is Jason N.'s real revenue forecast for Lympro:
So all his talk and fancy charts with huge numbers all boils down to him estimating 1.0m in 2015 and 3.5m in 2016 (of course it is printed in the smallest font possible).
I would love for him to be dead wrong and revenue be a grand slam. Notice that because the official "Zack's" stamp is on it (and it is not freelance) his numbers seem a lot more realistic. I find that interesting.
AMBS has enough dough for this year and has LPC for next year. They need to attract partnership attention ASAP. The longer they wait, the less Gerald has for leverage.
So all his talk and fancy charts with huge numbers all boils down to him estimating 1.0m in 2015 and 3.5m in 2016 (of course it is printed in the smallest font possible).
I would love for him to be dead wrong and revenue be a grand slam. Notice that because the official "Zack's" stamp is on it (and it is not freelance) his numbers seem a lot more realistic. I find that interesting.
AMBS has enough dough for this year and has LPC for next year. They need to attract partnership attention ASAP. The longer they wait, the less Gerald has for leverage.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼